NEWARK, Del, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings.
Besides antimicrobial resistance and unhealthy sedentary lifestyles, tobacco and alcohol consumption contribute to the rising non-communicable disease burden. This is because chronic diseases such as diabetes, cancer, and other autoimmune diseases become more prevalent.
Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16474
There are also several other factors contributing to the market's growth, including the development of healthcare infrastructure across developing countries, and technological advancements in wound management. The efforts made by healthcare providers and key players to make wound care more popular.
“Telehealth has played a key role in the strong recovery of the wound care market. Various healthcare providers have developed telehealth platforms to effectively manage patients with chronic and acute wounds.” says a lead analyst at Future Market Insights.
Key Takeaways from Market Study
- The market for anti-biofilm wound dressing is expected to record a CAGR of 9.5% over the forecast period.
- According to estimates, the anti-biofilm wound dressing market in North America may remain strong throughout the length of the forecast period.
- Acute wound segment dominated the market and is expected to record a CAGR of 9.3%.
Request for Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-16474
Competitive Landscape:
- Several prominent companies dominate this market, including ConvaTec, Smith & Nephew PLC, Urgo Medical, Coloplast, and 3M.
- Anti-biofilm wound dressing has developed significantly in the industry through partnerships, acquisitions, and research and development. These strategies have resulted in major developments.
- Recent Developments:
- Convatec Inc. acquired Triad Life Sciences Inc. in March 2022 for US$ 450 million. This acquisition was made with the aim of strengthening its portfolio of biomedical products for surgical wounds and chronic wounds.
- The FDA cleared an antimicrobial matrix product made by Imbed Biosciences, Microlyte Matrix, in April 2021. The product can be used to treat surgical, traumatic, and chronic wounds.
- For the treatment of diabetic foot ulcers, pressure ulcers, leg ulcers, and dehisced surgical wounds, ConvaTec Group Plc (ConvaTec) launched a new medication called "ConvaMax" in January 2020. As well as adhesion-free options, the product is also available in non-adhesive forms, allowing for total flexibility when it comes to integrating compression bands and other main dressings.
- In January 2018, Imbed Biosciences introduced the market with Microlyte Ag after raising over US$ 1.6 million to research silver-based anti-biofilm wound dressings.
- As a result of this acquisition, Smith & Nephew PLC expanded its product portfolio for advanced wound management, increasing its market share and customer base. In April 2019, the company acquired Osiris Therapeutics, Inc., a regenerative medicine company. As a result of this acquisition, the company will boost its growth by expanding its product portfolio for advanced wound management.
Key Companies Profiled
- ConvaTec
- Smith & Nephew PLC
- Urgo Medical
- Coloplast
- 3M
Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16474
Anti-biofilm Wound Dressing Market Segmentation by Category
By Mode of Mechanism:
- Physical
- Chemical
- Biological
By Wound Type:
- Chronic Wounds
- Acute Wounds
By End User:
- Hospitals and Clinics
- Surgical Centers
- Other End users
By Region:
- North America
- Latin America
- Europe
- The Middle East and Africa
- East Asia
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
Browse full Report@ https://www.futuremarketinsights.com/reports/anti-biofilm-wound-dressing-market
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain
Cell and Gene Therapy Manufacturing Market Size: The global sales of the Cell and Gene Therapy Manufacturing Market were held at US$ 15.6 billion in 2022, according to a recently published Future Market Insights analytical report on the market. The market is anticipated to grow at a CAGR of 29% from 2023 to 2033, reaching a US$ 240 billion valuation.
Cardiovascular Ultrasound Market Share: According to Future Market Insights' recently published Cardiovascular Ultrasound Market analysis report, the market's global revenue in 2022 was estimated to be US$ 1.2 billion. The market is anticipated to grow at a CAGR of 7.2% from 2023 to 2033.
Hidradenitis Suppurativa (HS) Treatment Market Growth: The global hidradenitis suppurativa (HS) treatment market is expected to surpass an impressive valuation of US$ 763.6 million in 2023, and is projected to reach US$ 1,240.9 million by 2033, expected to register a CAGR of 4.97%.
Hyperpigmentation Treatment Market Size: The global hyperpigmentation treatment market is expected to be valued at US$ 4.78 Billion in 2023 and is projected to exhibit a compound annual growth rate (CAGR) of 7.4% from 2023 to 2033.
Cancer Biopsy Market Share: According to a recently published analytical report by Future Market Insights, the global market for cancer biopsies will generate US$22.2 billion in sales in 2022. The market is anticipated to develop faster than it has in the past between 2023 and 2033, with a CAGR of 18%.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
